2018 Press Releases

Webcast ImageWebcast
Kindred Biosciences Inc at the Cantor Global Healthcare Conference (Live)
10/01/18 at 1:45 p.m. ET
Kindred Biosciences Inc at the Cantor Global Healthcare Conference
Monday, October 1, 2018 1:45 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Kindred Biosciences Inc at the Ladenburg Thalmann 2018 Healthcare Conference (Live)
10/02/18 at 3:00 p.m. ET
Kindred Biosciences Inc at the Ladenburg Thalmann 2018 Healthcare Conference
Tuesday, October 2, 2018 3:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Kindred Biosciences to Present at Cantor Global Healthcare Conference and Ladenburg Thalmann 2018 Healthcare Conference

September 17, 2018

SAN FRANCISCO, Sept. 17, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare Conference

August 21, 2018

SAN FRANCISCO, Aug. 21, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Second Quarter 2018 Financial Results

August 9, 2018

SAN FRANCISCO, Aug. 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Second Quarter 2018 Financial Results

July 16, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Announces Commercial Availability of Mirataz® (mirtazapine transdermal ointment) to Veterinarians in the United States

July 9, 2018

SAN FRANCISCO, July 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

June 25, 2018

SAN FRANCISCO, June 25, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces the Termination of Its At-The-Market Equity Offering Program

June 20, 2018

SAN FRANCISCO, June 20, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Pricing of Public Offering

June 20, 2018

SAN FRANCISCO, June 20, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Proposed Public Offering of Common Stock

June 19, 2018

SAN FRANCISCO, June 19, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

KindredBio Announces Positive Results from Pilot Effectiveness Study of KIND-014 for the Treatment of Gastric Ulcers in Horses

May 30, 2018

SAN FRANCISCO, May 30, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Present at Jefferies 2018 Global Healthcare Conference and 8th Annual LD Micro Invitational Conference

May 29, 2018

SAN FRANCISCO, May 29, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Present at Stifel 2018 Dental & Veterinary Conference

May 24, 2018

SAN FRANCISCO, May 24, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces First Quarter 2018 Financial Results

May 8, 2018

SAN FRANCISCO, May 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences Receives FDA Approval of Mirataz™ (mirtazapine transdermal ointment) for the Management of Weight Loss in Cats

May 7, 2018

SAN FRANCISCO, May 7, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences Announces the Appointment of Dr. Ernest Mario and Dr. Joseph McCracken to its Board of Directors

April 25, 2018

SAN FRANCISCO, April 25, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences Provides Updates on Pending Drug Approvals

April 24, 2018

SAN FRANCISCO, April 24, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Announce First Quarter 2018 Financial Results

April 18, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

March 8, 2018

SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

March 1, 2018

SAN FRANCISCO, March 1, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results

February 15, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

February 13, 2018

SAN FRANCISCO, Feb. 13, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...